Filing Details
Biohaven Ltd. (NYSE:BHVN) filed a Form 8-K with the Securities and Exchange Commission on July 09, 2026, disclosing a material event.
8k filedNYSE:BHVN
Biohaven Ltd. (BHVN) Reports Material Event to SEC
Filing Details Biohaven Ltd. (NYSE:BHVN) filed a Form 8-K with the Securities and Exchange Commission on July 09, 2026, disclosing a material event. Market Context Biohaven Ltd.'s…
Market Context
Biohaven Ltd.'s stock currently trades at $16.79 with a market capitalization of $1.2B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Biohaven Ltd.'s stock.
All SEC filings for Biohaven Ltd. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BHVN Stock Page
Frequently Asked Questions
Where can I read BHVN's SEC filings?
Browse all filings on our BHVN SEC filings page.
What types of SEC filings does Biohaven Ltd. file?
Public companies like Biohaven Ltd. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
